Literature DB >> 26101048

Analysis of Causes and Risk Factors for Hospital Readmission After Roux-en-Y Gastric Bypass.

Azucena Reyes-Pérez1, Hugo Sánchez-Aguilar1, David Velázquez-Fernández1, Donají Rodríguez-Ortíz1, Maureen Mosti1, Miguel F Herrera2.   

Abstract

BACKGROUND: Identification of causes and preventable triggers for hospital readmission after bariatric surgery is very important to implement strategies for surgical outcome optimization. The aim of the study was to analyze our readmissions after a Roux-en-Y gastric bypass (RYGB). PATIENTS AND METHODS: From our prospectively constructed database, patients who were readmitted to the hospital within the following 30 and 90 days after discharge were analyzed. Hospital charts were reviewed to determine the cause of readmission and the outcome. Potential risk factors for readmission were statistically analyzed.
RESULTS: Between June 2004 and November 2013, 657 patients underwent a primary RYGB and 100 revisions. There were 442 (58%) females and 315 (42%) males with a mean age of 40.1 ± 11.5 years and a mean BMI of 42.4 ± 6.5 Kg/m(2). Comorbidities were present in 441 (58.2%) patients. Operations were completed laparoscopically in 741 (97.8%) patients. Mean hospital stay after the RYGB was 2.5 ± 1.6 days. The 30-day and 90-day readmission rate was 2.6 and 4.58%, respectively. Most common causes for readmission at 30 days were gastrointestinal bleeding in 30%, lung disease in 15%, and food intolerance in 15%. At 90 days, they were stricture of the gastrojejunostomy in 20%, gastrointestinal bleeding in 13.3%, and nephrolithiasis in 13.3%. Open surgery and previous upper abdominal surgery were significant risk factors for 90-day readmission.
CONCLUSION: Our readmission rate after RYGB was low. Most common causes for readmission were upper gastrointestinal bleeding and food intolerance. Associated risk factors were open surgery and previous upper abdominal surgery.

Entities:  

Keywords:  Bariatric surgery; Hospital readmission; Morbidity; Mortality; Roux-en-Y gastric bypass

Mesh:

Year:  2016        PMID: 26101048     DOI: 10.1007/s11695-015-1755-y

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  15 in total

1.  One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass.

Authors:  John Saunders; Garth H Ballantyne; Scott Belsley; Daniel J Stephens; Amit Trivedi; Douglas R Ewing; Vincent A Iannace; Rafael F Capella; Annette Wasileweski; Steven Moran; Hans J Schmidt
Journal:  Obes Surg       Date:  2008-05-02       Impact factor: 4.129

2.  Implementation of designated bariatric surgery program leads to improved clinical outcomes.

Authors:  Kristoffel R Dumon; P Kaitlyn Edelson; Steven E Raper; Katie Foster-Kilgarriff; Noel N Williams
Journal:  Surg Obes Relat Dis       Date:  2011-02-26       Impact factor: 4.734

Review 3.  Why readmissions matter….

Authors:  Matthew Hutter
Journal:  Surg Obes Relat Dis       Date:  2014-03-01       Impact factor: 4.734

Review 4.  Working together: regional collaboration and readmissions.

Authors:  Stuart R Verseman; Nancy J O Birkmeyer
Journal:  Surg Obes Relat Dis       Date:  2014-03-01       Impact factor: 4.734

5.  Optimizing outcomes in bariatric surgery: outpatient laparoscopic gastric bypass.

Authors:  Todd M McCarty; David T Arnold; Jeffrey P Lamont; Tammy L Fisher; Joseph A Kuhn
Journal:  Ann Surg       Date:  2005-10       Impact factor: 12.969

6.  Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass.

Authors:  Eric J DeMaria; Dana Portenier; Luke Wolfe
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

7.  Factors associated with readmission after laparoscopic gastric bypass surgery.

Authors:  Brian Hong; Edwin Stanley; Susan Reinhardt; Kristen Panther; Michael J Garren; Jon C Gould
Journal:  Surg Obes Relat Dis       Date:  2011-06-15       Impact factor: 4.734

Review 8.  Bariatric procedures: an update on techniques, outcomes and complications.

Authors:  Veronica Baptista; Wahid Wassef
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

9.  Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass.

Authors:  Todd Andrew Kellogg; Therese Swan; Daniel A Leslie; Henry Buchwald; Sayeed Ikramuddin
Journal:  Surg Obes Relat Dis       Date:  2009-01-31       Impact factor: 4.734

10.  Risk for hospital readmission following bariatric surgery.

Authors:  Robert B Dorman; Christopher J Miller; Daniel B Leslie; Federico J Serrot; Bridget Slusarek; Henry Buchwald; John E Connett; Sayeed Ikramuddin
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

View more
  4 in total

1.  Patterns of hospital utilization after elective minimally invasive foregut surgery.

Authors:  Anahita D Jalilvand; Monet McNally; Patricia Belle; Kyle A Perry
Journal:  Surg Endosc       Date:  2019-07-12       Impact factor: 4.584

2.  Readmissions After Bariatric Surgery in France, 2013-2016: a Nationwide Study on Administrative Data.

Authors:  Andrea Lazzati; Gilles Chatellier; Sandrine Katsahian
Journal:  Obes Surg       Date:  2019-11       Impact factor: 4.129

3.  Randomized, Double-Blind Study of the Effect of Intraoperative Intravenous Lidocaine on the Opioid Consumption and Criteria for Hospital Discharge After Bariatric Surgery.

Authors:  Rioko K Sakata; Roclides C de Lima; Jose A Valadão; Plinio C Leal; Ed Cr Moura; Vitor P Cruz; Caio Mb de Oliveira
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

4.  Risk Factors for Prolonged Length of Hospital Stay and Readmissions After Laparoscopic Sleeve Gastrectomy and Laparoscopic Roux-en-Y Gastric Bypass.

Authors:  Piotr Major; Michał Wysocki; Grzegorz Torbicz; Natalia Gajewska; Alicja Dudek; Piotr Małczak; Michał Pędziwiatr; Magdalena Pisarska; Dorota Radkowiak; Andrzej Budzyński
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.